findmyKOL

Raymond Grenfell, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionJackson, MS · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Raymond Grenfell is an Endocrinology/Metabolic physician. OpenAlex indexes 20 publications with 200 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
20publications

Distinct works indexed by OpenAlex.

200citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    41.7%
    Insulin Analog11.6%
    Novolog Flexpen20%Tresiba Flextouch U-10016%Novolog12%Soliqua 100-3310%Tresiba Flextouch U-2008%Toujeo Solostar7%Humalog5%Lantus Solostar5%Humalog Kwikpen U-1004%Insulin Lispro3%Lantus3%Levemir Flexpen3%Basaglar Kwikpen U-1002%Fiasp Flextouch2%Lyumjev Kwikpen U-1001%
    Part D<11 patients
    Biguanide (metformin)6.3%
    Metformin Hcl65%Metformin Hcl Er35%
    Part D120 patients

    + 12 more classes in this area

  • Cardiovascular

    32.1%
    Statin12.1%
    Atorvastatin Calcium38%Pravastatin Sodium27%Rosuvastatin Calcium26%Simvastatin7%Lovastatin1%Livalo1%
    Part D<11 patients
    ACE inhibitor4.2%
    Lisinopril48%Ramipril27%Lisinopril-Hydrochlorothiazide15%Enalapril Maleate7%Trandolapril4%
    Part D<11 patients

    + 14 more classes in this area

  • Hormonal (systemic)

    22.1%
    l-Thyroxine21.1%
    Synthroid63%Levothyroxine Sodium36%Levoxyl1%
    Part D<11 patients
    Calcium-sensing Receptor Agonist0.4%
    Cinacalcet Hcl100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”